查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951949

生物技术原料市场分析及预测（至2035年）：依类型、产品类型、服务、技术、成分、应用、形式、製程及最终用户划分

Biotech Ingredients Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Form, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 336 Pages | 商品交期: 3-5个工作天内

价格
简介目录

生技原料市场预计将从2024年的29亿美元成长到2034年的73亿美元，复合年增长率约为8.1%。生物技术原料市场涵盖製药、化妆品和食品产业所使用生物基物质的生产和应用。这些原料生物来源，为产品配方提供永续的创新解决方案。生物技术的进步、消费者对天然产品日益增长的需求以及对环保实践的监管支持是推动市场成长和多元化发展的驱动因素，这些因素正在促进生物技术原料市场在各种应用领域的发展。

生物技术原料市场预计将迎来显着成长，这主要得益于生物技术的进步和对永续解决方案日益增长的需求。製药领域正成为成长最快的细分市场，这主要受创新药物配方和个人化医疗需求的推动。在该领域，酶因其在药物合成和生物催化方面的应用而备受关注。化妆品和个人护理行业也紧随其后，胜肽和蛋白质等活性成分能够提升产品功效和消费者吸引力。机能性食品原料市场也在蓬勃发展，这主要得益于人们健康意识的提高和对强化食品的需求。益生菌和益生元因其对促进肠道健康和整体健康的关键作用而脱颖而出。生物技术衍生的香精香料作为合成化合物的天然永续替代品，也越来越受到重视。持续的研发投入和策略合作推动了市场成长，这些投入和合作正在推动创新并加速产品开发。

市场区隔
类型 胺基酸、酵素、维生素、有机酸、抗生素、荷尔蒙、生物聚合物
产品 重组蛋白、单株抗体、疫苗、细胞培养基、生物製药、诊断剂
服务 契约製造、客製化合成、製程开发、分析服务、咨询和法规支持
科技 发酵、生物催化、细胞培养、基因工程、合成生物学、代谢工程
成分 原料、中间体、活性成分、添加剂
目的 製药、食品饮料、农业、化妆品、饲料、生质燃料
形式 液体、粉末、颗粒、丸剂
过程 上游工程、下游製程、配方、纯化
最终用户 製药公司、生技公司、研究机构、受託研究机构

生技原料市场呈现动态的市场格局，创新和策略联盟对市场占有率有显着影响。新产品的推出和对成本效益的追求导致了日益激烈的定价竞争。近期产品推出丰富了产品线，提升了生物技术原料在各个细分市场的吸引力。各公司正利用技术进步来优化生产流程、维持竞争优势并确保永续成长。竞争基准分析显示，该市场竞争异常激烈，主要企业透过研发争夺主导。在安全和品质标准严格的地区，法规的影响尤其显着。这些法规塑造了市场动态，并迫使企业遵守严格的合规措施。在对永续和生物基解决方案日益增长的需求驱动下，该市场展现出强劲的成长潜力。随着创新不断加速，在生物技术进步和消费者对环保产品偏好的推动下，生物技术原料市场可望迎来变革性成长。

主要趋势和驱动因素：

受消费者对永续和天然来源产品需求不断增长的推动，生技原料市场正经历显着成长。一个关键趋势是转向生物基原料，这主要源自于消费者对环保产品的偏好。生物技术的进步进一步推动了这一趋势，使得高品质、永续原料的生产成为可能。另一个重要趋势是个人化营养的兴起，这推动了对根据个人健康需求量身定制的生物技术原料的需求。此外，製药业在药物製剂中对生技原料的日益依赖也是一个关键驱动因素。市场也看到研发投入不断增加，致力于开发具有增强功能的新型原料。新兴市场对生技原料的需求正在快速成长，这带来了巨大的机会。专注于创新和永续性的公司将占据有利地位，从而获得市场份额。此外，策略伙伴关係和合作对于利用专业知识和扩展产品系列至关重要，这将有助于企业在这个充满活力的市场中获得竞争优势。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 胺基酸
    • 酵素
    • 维他命
    • 有机酸
    • 抗生素
    • 荷尔蒙
    • 生物聚合物
  • 市场规模及预测：依产品划分
    • 重组蛋白
    • 单株抗体
    • 疫苗
    • 细胞培养基
    • 生物製药
    • 诊断剂
  • 市场规模及预测：依服务划分
    • 契约製造
    • 客製合成
    • 製程开发
    • 分析服务
    • 咨询
    • 监管支持
  • 市场规模及预测：依技术划分
    • 发酵
    • 生物催化剂
    • 细胞培养
    • 基因工程
    • 合成生物学
    • 代谢工程
  • 市场规模及预测：依组件划分
    • 原料
    • 中级
    • 活性成分
    • 添加剂
  • 市场规模及预测：依应用领域划分
    • 製药
    • 饮食
    • 农业
    • 化妆品
    • 动物饲料
    • 生质燃料
  • 市场规模及预测：依类型
    • 液体
    • 粉末
    • 颗粒
    • 颗粒
  • 市场规模及预测：依製程划分
    • 上游工程
    • 下游工艺
    • 配方
    • 纯化
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 生技公司
    • 研究所
    • 合约研究机构

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Lonza Group
  • Catalent
  • Evonik Industries
  • Fujifilm Diosynth Biotechnologies
  • Corbion
  • Wacker Chemie
  • Croda International
  • Novozymes
  • Merck KGa A
  • Bio Vectra
  • Cambrex Corporation
  • Ajinomoto Bio Pharma Services
  • Sartorius
  • Genomatica
  • Almac Group
  • Boehringer Ingelheim Bio Xcellence
  • Ginkgo Bioworks
  • Biocon
  • Rentschler Biopharma
  • AGC Biologics

第九章：关于我们

简介目录
Product Code: GIS32197

Biotech Ingredients Market is anticipated to expand from $2.9 billion in 2024 to $7.3 billion by 2034, growing at a CAGR of approximately 8.1%. The Biotech Ingredients Market encompasses the production and utilization of bio-based substances used in pharmaceuticals, cosmetics, and food industries. These ingredients, derived from living organisms, offer sustainable and innovative solutions for product formulation. The market is driven by advances in biotechnology, increasing consumer demand for natural products, and regulatory support for eco-friendly practices, fostering growth and diversification across applications.

The Biotech Ingredients Market is poised for significant growth, driven by advancements in biotechnology and increasing demand for sustainable solutions. The pharmaceutical segment emerges as the top-performing sub-segment, propelled by the need for innovative drug formulations and personalized medicine. Enzymes, within this segment, are gaining prominence due to their application in drug synthesis and biocatalysis. The cosmetics and personal care sub-segment follows closely, with active ingredients like peptides and proteins enhancing product efficacy and consumer appeal. Functional food ingredients are also witnessing an upward trajectory, fueled by the rising health consciousness and demand for fortified foods. Probiotics and prebiotics stand out as key contributors, promoting gut health and overall well-being. Biotech flavors and fragrances are gaining traction, offering natural and sustainable alternatives to synthetic compounds. The market's growth is underpinned by continuous R&D investments and strategic collaborations, fostering innovation and expediting product development.

Market Segmentation
TypeAmino Acids, Enzymes, Vitamins, Organic Acids, Antibiotics, Hormones, Biopolymers
ProductRecombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Culture Media, Biopharmaceuticals, Diagnostic Reagents
ServicesContract Manufacturing, Custom Synthesis, Process Development, Analytical Services, Consultancy, Regulatory Support
TechnologyFermentation, Biocatalysis, Cell Culture, Genetic Engineering, Synthetic Biology, Metabolic Engineering
ComponentRaw Materials, Intermediates, Active Ingredients, Excipients
ApplicationPharmaceutical, Food and Beverage, Agriculture, Cosmetics, Animal Feed, Biofuels
FormLiquid, Powder, Granule, Pellet
ProcessUpstream Processing, Downstream Processing, Formulation, Purification
End UserPharmaceutical Companies, Biotechnology Firms, Research Institutes, Contract Research Organizations

The Biotech Ingredients Market is characterized by a dynamic landscape where market share is primarily influenced by innovation and strategic alliances. Pricing strategies are increasingly competitive, driven by the introduction of novel products and the pursuit of cost efficiency. Recent product launches have diversified offerings, enhancing the appeal of biotech ingredients across various sectors. Companies are leveraging technological advancements to optimize production processes, thereby maintaining a competitive edge and ensuring sustainable growth. Competition benchmarking reveals a market marked by intense rivalry, with key players vying for leadership through research and development. Regulatory influences are significant, particularly in regions with stringent safety and quality standards. These regulations shape market dynamics, compelling companies to adhere to rigorous compliance measures. The market exhibits robust growth potential, fueled by increasing demand for sustainable and bio-based solutions. As innovation continues to accelerate, the biotech ingredients market is poised for transformative growth, driven by advancements in biotechnology and consumer preference for eco-friendly products.

Geographical Overview:

The biotech ingredients market is experiencing notable growth across various regions, each presenting unique opportunities. North America leads, driven by advanced biotech research and a robust pharmaceutical industry. The region's focus on innovation and sustainable practices further propels market growth. Europe follows, with strong regulatory frameworks and investments in biotechnology fostering a conducive environment for market expansion. Asia Pacific is emerging as a significant growth pocket, fueled by increasing investments in biotech research and development. Countries like China and India are at the forefront, leveraging their vast resources and skilled workforce. Latin America and the Middle East & Africa are also gaining traction, with rising awareness and adoption of biotech solutions. Brazil and South Africa are key players, recognizing the potential of biotech ingredients in enhancing various industries. These regions offer lucrative opportunities for stakeholders aiming to capitalize on the burgeoning demand for sustainable and innovative biotech solutions.

Global tariffs and geopolitical risks are significantly influencing the Biotech Ingredients Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are diversifying their supply chains to mitigate tariff impacts, investing in local biotech innovation. China, facing trade tensions, is accelerating the development of its domestic biotech capabilities, while Taiwan's strategic position in the semiconductor industry also affects its biotech sector. The global market for biotech ingredients is robust, driven by demand for innovative pharmaceuticals and sustainable solutions. By 2035, the market is poised for substantial growth, contingent on geopolitical stability and supply chain resilience. Middle East conflicts add complexity, potentially disrupting global supply chains and affecting energy prices, which in turn could influence production costs and timelines in the biotech sector.

Key Trends and Drivers:

The biotech ingredients market is experiencing notable growth, driven by the increasing demand for sustainable and natural products. Key trends include the shift towards bio-based ingredients, fueled by consumer preference for environmentally friendly products. This trend is further supported by advancements in biotechnology, enabling the production of high-quality, sustainable ingredients. Another significant trend is the rise in personalized nutrition, which is driving the demand for customized biotech ingredients tailored to individual health needs. Additionally, the pharmaceutical industry's growing reliance on biotech ingredients for drug formulation is a crucial driver. The market is also witnessing increased investment in research and development to create novel ingredients with enhanced functionalities. Opportunities are abundant in emerging markets, where the demand for biotech ingredients is expanding rapidly. Companies focusing on innovation and sustainability are well-positioned to capture market share. Furthermore, strategic partnerships and collaborations are becoming essential to leverage expertise and expand product portfolios, ensuring competitive advantage in this dynamic market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Form
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Amino Acids
    • 4.1.2 Enzymes
    • 4.1.3 Vitamins
    • 4.1.4 Organic Acids
    • 4.1.5 Antibiotics
    • 4.1.6 Hormones
    • 4.1.7 Biopolymers
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Recombinant Proteins
    • 4.2.2 Monoclonal Antibodies
    • 4.2.3 Vaccines
    • 4.2.4 Cell Culture Media
    • 4.2.5 Biopharmaceuticals
    • 4.2.6 Diagnostic Reagents
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Contract Manufacturing
    • 4.3.2 Custom Synthesis
    • 4.3.3 Process Development
    • 4.3.4 Analytical Services
    • 4.3.5 Consultancy
    • 4.3.6 Regulatory Support
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Fermentation
    • 4.4.2 Biocatalysis
    • 4.4.3 Cell Culture
    • 4.4.4 Genetic Engineering
    • 4.4.5 Synthetic Biology
    • 4.4.6 Metabolic Engineering
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Raw Materials
    • 4.5.2 Intermediates
    • 4.5.3 Active Ingredients
    • 4.5.4 Excipients
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Pharmaceutical
    • 4.6.2 Food and Beverage
    • 4.6.3 Agriculture
    • 4.6.4 Cosmetics
    • 4.6.5 Animal Feed
    • 4.6.6 Biofuels
  • 4.7 Market Size & Forecast by Form (2020-2035)
    • 4.7.1 Liquid
    • 4.7.2 Powder
    • 4.7.3 Granule
    • 4.7.4 Pellet
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Upstream Processing
    • 4.8.2 Downstream Processing
    • 4.8.3 Formulation
    • 4.8.4 Purification
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Pharmaceutical Companies
    • 4.9.2 Biotechnology Firms
    • 4.9.3 Research Institutes
    • 4.9.4 Contract Research Organizations

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Form
      • 5.2.1.8 Process
      • 5.2.1.9 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Form
      • 5.2.2.8 Process
      • 5.2.2.9 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Form
      • 5.2.3.8 Process
      • 5.2.3.9 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Form
      • 5.3.1.8 Process
      • 5.3.1.9 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Form
      • 5.3.2.8 Process
      • 5.3.2.9 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Form
      • 5.3.3.8 Process
      • 5.3.3.9 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Form
      • 5.4.1.8 Process
      • 5.4.1.9 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Form
      • 5.4.2.8 Process
      • 5.4.2.9 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Form
      • 5.4.3.8 Process
      • 5.4.3.9 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Form
      • 5.4.4.8 Process
      • 5.4.4.9 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Form
      • 5.4.5.8 Process
      • 5.4.5.9 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Form
      • 5.4.6.8 Process
      • 5.4.6.9 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Form
      • 5.4.7.8 Process
      • 5.4.7.9 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Form
      • 5.5.1.8 Process
      • 5.5.1.9 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Form
      • 5.5.2.8 Process
      • 5.5.2.9 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Form
      • 5.5.3.8 Process
      • 5.5.3.9 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Form
      • 5.5.4.8 Process
      • 5.5.4.9 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Form
      • 5.5.5.8 Process
      • 5.5.5.9 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Form
      • 5.5.6.8 Process
      • 5.5.6.9 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Form
      • 5.6.1.8 Process
      • 5.6.1.9 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Form
      • 5.6.2.8 Process
      • 5.6.2.9 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Form
      • 5.6.3.8 Process
      • 5.6.3.9 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Form
      • 5.6.4.8 Process
      • 5.6.4.9 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Form
      • 5.6.5.8 Process
      • 5.6.5.9 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Lonza Group
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Catalent
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Evonik Industries
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Fujifilm Diosynth Biotechnologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Corbion
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Wacker Chemie
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Croda International
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Novozymes
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Merck KGa A
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bio Vectra
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Cambrex Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Ajinomoto Bio Pharma Services
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sartorius
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Genomatica
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Almac Group
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Boehringer Ingelheim Bio Xcellence
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ginkgo Bioworks
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biocon
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Rentschler Biopharma
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 AGC Biologics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us